Nevirapine will lower the level or influence of ergotamine by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. caffeine will improve the amount or outcome of fezolinetant by affecting hepatic enzyme CYP1A2 metabolism. Contraindicated. Fezolinetant AUC and peak plasma concentration are improved if coadministered with drugs which might be weak, reasonable, or https://robertq629tqm1.thelateblog.com/profile